Len Verbeke
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Liver physiology and pathology
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 10
- Liver Disease and Transplantation 9
-
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Wim Laleman (17 shared papers)Frederik Nevens (10 shared papers)Ricard Farré (8 shared papers)Jonel Trebicka (7 shared papers)Petra Windmolders (5 shared papers)Ingrid Vander Elst (5 shared papers)Sabine Klein (4 shared papers)Tania Roskams (4 shared papers)
- Journals
- Journal of Hepatology (5 papers)Hepatology (2 papers)PLoS ONE (2 papers)Gut (2 papers)Endoscopy (2 papers)
- Partner nations
- BelgiumGermanyNetherlands
In The Last Decade
Len Verbeke
28 papers receiving 1.8k citations
Len Verbeke's Hit Papers
Peers
Comparison fields: 5 of 75
- Hepatology 765
- Epidemiology 960
- Pharmacology 142
- Oncology 315
- Endocrinology, Diabetes and Metabolism 195
Countries citing papers authored by Len Verbeke
This map shows the geographic impact of Len Verbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Len Verbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Len Verbeke more than expected).
Fields of papers citing papers by Len Verbeke
This network shows the impact of papers produced by Len Verbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Len Verbeke. The network helps show where Len Verbeke may publish in the future.
Co-authors
The 25 scholars most cited alongside Len Verbeke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 404 |
| 2 | 2013 | 229 | |
| 3 | 2016 | 206 | |
| 4 | 2015 | 192 | |
| 5 | 2001 | 125 | |
| 6 | 2012 | 114 | |
| 7 | 2018 | 84 | |
| 8 | 2011 | 80 | |
| 9 | 2017 | 76 | |
| 10 | 2015 | 63 | |
| 11 | 2017 | 54 | |
| 12 | 2011 | 46 | |
| 13 | 2017 | 38 | |
| 14 | The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease. | 2018 | 33 |
| 15 | 2017 | 19 | |
| 16 | 2015 | 17 | |
| 17 | 2009 | 16 | |
| 18 | 2019 | 13 | |
| 19 | 2018 | 6 | |
| 20 | 2018 | 6 |
About Len Verbeke
Len Verbeke is a scholar working on Hepatology, Pharmacology, Epidemiology, Oncology and Surgery, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Organ Transplantation Techniques and Outcomes (3 papers), Gallbladder and Bile Duct Disorders (2 papers), Diet, Metabolism, and Disease (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). The work is most often cited by research in Hepatology (765 citations), Epidemiology (960 citations), Pharmacology (142 citations), Oncology (315 citations) and Endocrinology, Diabetes and Metabolism (195 citations). Len Verbeke has collaborated with scholars based in Belgium, Germany and Netherlands. Frequent co-authors include Wim Laleman, Frederik Nevens, Ricard Farré, Jonel Trebicka, Petra Windmolders, Ingrid Vander Elst, Sabine Klein, Tania Roskams, Tim Vanuytsel and Mina Komuta. Their work appears in journals such as Journal of Hepatology, Hepatology, PLoS ONE, Gut and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.